Before medication begins, a Twin provider reviews the members labs, weight, current medications, and health history
It is a naturally occurring antioxidant that is generally well-tolerated
Medical history, contraindications, financial considerations, adherence capacity, and personal preferences all influence treatment selection
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
The active GLP-1 assays were performed by Medicilon Preclinical Research LLC